Schreiber S, Cross RK, Panaccione R, D'Haens G, et al. Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease. Aliment Pharmacol Ther 2024 Jul 25. doi: 10.1111/apt.18184.
PMID: 39054592